[go: up one dir, main page]

TN2009000100A1 - Silicon derivatives for pet imaging - Google Patents

Silicon derivatives for pet imaging

Info

Publication number
TN2009000100A1
TN2009000100A1 TN2009000100A TN2009000100A TN2009000100A1 TN 2009000100 A1 TN2009000100 A1 TN 2009000100A1 TN 2009000100 A TN2009000100 A TN 2009000100A TN 2009000100 A TN2009000100 A TN 2009000100A TN 2009000100 A1 TN2009000100 A1 TN 2009000100A1
Authority
TN
Tunisia
Prior art keywords
pet imaging
silicon derivatives
compounds
derivatives
silicon
Prior art date
Application number
TN2009000100A
Other languages
English (en)
Inventor
Ananth Srinivasan
Lutz Lehmann
Ulrike Voigtmann
Timo Stellfeld
Simon Ametamey
Ulrich Klar
Aileen Hohne
Linjing Mu
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06076823A external-priority patent/EP1908472A1/fr
Priority claimed from EP06076869A external-priority patent/EP1911452A1/fr
Priority claimed from EP07090043A external-priority patent/EP1970064A1/fr
Priority claimed from EP07090079A external-priority patent/EP1985624A3/fr
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of TN2009000100A1 publication Critical patent/TN2009000100A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13Labelling of peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/695Silicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/14Peptides, e.g. proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0491Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/004Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/008Peptides; Proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0834Compounds having one or more O-Si linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0896Compounds with a Si-H linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/12Organo silicon halides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086Bombesin; Related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Nuclear Medicine (AREA)
TN2009000100A 2006-10-02 2009-03-25 Silicon derivatives for pet imaging TN2009000100A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP06076823A EP1908472A1 (fr) 2006-10-02 2006-10-02 Dérivés de silicone pour l'imagerie TEP
EP06076869A EP1911452A1 (fr) 2006-10-11 2006-10-11 Dérivés de silicone pour l'imagerie TEP
EP07090043A EP1970064A1 (fr) 2007-03-12 2007-03-12 Dérivés de silicone pour l'imagerie TEP
EP07090079A EP1985624A3 (fr) 2007-04-23 2007-04-23 Procédé simple de radiofluorination de composés actifs biologiquement ou de biomolécules
PCT/EP2007/008044 WO2008040441A2 (fr) 2006-10-02 2007-09-07 Radiofluoration

Publications (1)

Publication Number Publication Date
TN2009000100A1 true TN2009000100A1 (en) 2010-08-19

Family

ID=39030886

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2009000100A TN2009000100A1 (en) 2006-10-02 2009-03-25 Silicon derivatives for pet imaging

Country Status (21)

Country Link
US (1) US20090035215A1 (fr)
EP (1) EP2074135A2 (fr)
JP (1) JP2010505776A (fr)
KR (1) KR20090085599A (fr)
AR (1) AR062795A1 (fr)
AU (1) AU2007304508A1 (fr)
BR (1) BRPI0719956A2 (fr)
CA (1) CA2664700A1 (fr)
CO (1) CO6180444A2 (fr)
CR (1) CR10703A (fr)
IL (1) IL197817A0 (fr)
MA (1) MA30824B1 (fr)
MX (1) MX2009003617A (fr)
NO (1) NO20091735L (fr)
PA (1) PA8747601A1 (fr)
PE (1) PE20081173A1 (fr)
SV (1) SV2009003205A (fr)
TN (1) TN2009000100A1 (fr)
TW (1) TW200820988A (fr)
UY (1) UY30596A1 (fr)
WO (1) WO2008040441A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2627486T3 (es) 2010-01-25 2017-07-28 Institut National De La Sante Et De La Recherche Medicale (Inserm) Biomoléculas sililadas
JP5717138B2 (ja) * 2011-05-23 2015-05-13 独立行政法人産業技術総合研究所 タンパク質固定化表面修飾材料
CN105452262A (zh) * 2013-06-06 2016-03-30 日产化学工业株式会社 烷氧基硅烷化合物、液晶取向剂、液晶取向膜和液晶表示元件
CA2982269C (fr) * 2015-05-26 2023-12-05 The Regents Of The University Of California Accepteurs silicium-fluorure heteroaromatiques utiles pour de marquage 18f de molecules et de biomolecules, et methodes de preparation
US11464784B2 (en) 2017-09-15 2022-10-11 The Regents Of The University Of California Inhibition of aminocylase 3 (AA3) in the treatment of cancer
WO2021226076A1 (fr) * 2020-05-04 2021-11-11 The Research Foundation For The State University Of New York Composition d'agent d'imagerie pour tomographie par émission de positrons et procédé de détection d'infection bactérienne
WO2022064812A1 (fr) * 2020-09-28 2022-03-31 国立研究開発法人量子科学技術研究開発機構 Procédé de production d'une substance marquée radioactive, dispositif de production d'une substance marquée radioactive, et procédé d'évaporation et de concentration de nucléide métallique radioactif

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084555A (en) * 1989-08-21 1992-01-28 The Administrators Of The Tulane Educational Fund An octapeptide bombesin analog
US5732578A (en) * 1995-02-24 1998-03-31 Hyundai Metal Co., Ltd. Device for maintaining the horizontality of a door lock lever
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
US6639076B1 (en) * 1998-08-18 2003-10-28 Eli Lilly And Company Growth hormone secretagogues
DE60022508T2 (de) * 1999-06-14 2006-06-08 Eli Lilly And Co., Indianapolis Inhibitoren von serin proteasen
WO2002044144A2 (fr) * 2000-11-30 2002-06-06 Advanced Research And Technology Institute, Inc. Utilisation de nucleophiles pour preparer des agents d'imagerie radiomarques, et composes associes
GB0206750D0 (en) * 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
US7342095B2 (en) * 2003-02-20 2008-03-11 University Of South Florida Peptidomimetic inhibitors of STAT activity and uses thereof
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
WO2005077967A1 (fr) * 2004-02-13 2005-08-25 The University Of British Columbia Composes et compositions radiomarques, leurs precurseurs et leurs procedes de production
US20080029548A1 (en) * 2006-05-05 2008-02-07 Ann De Wree Fabric treatment dispensing package

Also Published As

Publication number Publication date
AU2007304508A8 (en) 2009-05-14
MX2009003617A (es) 2009-04-22
SV2009003205A (es) 2009-10-19
JP2010505776A (ja) 2010-02-25
WO2008040441A3 (fr) 2009-01-08
UY30596A1 (es) 2008-05-02
CO6180444A2 (es) 2010-07-19
PA8747601A1 (es) 2009-08-26
EP2074135A2 (fr) 2009-07-01
US20090035215A1 (en) 2009-02-05
NO20091735L (no) 2009-06-30
WO2008040441A2 (fr) 2008-04-10
PE20081173A1 (es) 2008-11-06
AU2007304508A1 (en) 2008-04-10
MA30824B1 (fr) 2009-10-01
BRPI0719956A2 (pt) 2014-04-29
TW200820988A (en) 2008-05-16
AR062795A1 (es) 2008-12-03
CR10703A (es) 2009-06-25
IL197817A0 (en) 2009-12-24
CA2664700A1 (fr) 2008-04-10
KR20090085599A (ko) 2009-08-07

Similar Documents

Publication Publication Date Title
TN2009000063A1 (en) Compounds and methods for 18f labeled agents
TN2011000279A1 (en) Novel pyrazole -4-n-alkoxycarboxamides as microbiocides
BRPI0908926A2 (pt) Compostos de policarbonato-poliorganosiloxano e/ou poliuretano-poliorganosiloxano
IL181529A0 (en) Diagnostic compounds
TN2009000100A1 (en) Silicon derivatives for pet imaging
WO2009046842A3 (fr) Dérivés de thiazole
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
ATE522249T1 (de) Organische verbindungen
WO2009024342A3 (fr) Nouveaux microbiocides
MX2009004435A (es) Tinturas dispersas, su preparacion y su uso.
MX2010005649A (es) Compuestos novedosos como ligandos del receptor canabinoide y sus usos.
TNSN07383A1 (en) 1-h-quinazoline-2,4-diones and their use as ampa-receptor ligands
EP2253318A4 (fr) Amélioration de la solubilité d'une préparation contenant de l'olmésartan médoxomil
UA96994C2 (ru) Производные 7-алкинил-1,8-нафтиридонов, способ их получения и их применения в терапии
WO2008151828A8 (fr) Nouveaux microbiocides
IL200469A0 (en) Benzimidazole derivatives
EA200901142A1 (ru) 18f фторбензоильные меченые биологически активные соединения в качестве диагностических визуализирующих средств, а также бензотриазол-1-илоксибензоильные, 2,5-(диоксопирролидин-1-илокси)бензоильные и триметиламмониобензоильные предшественники
MX2011007266A (es) Microbiocidas nuevos.
WO2009127718A3 (fr) Nouveaux microbiocides
MX2009012471A (es) Compuestos 4´sustituidos que tienen afinidad al receptor 5-hidroxitriptamina 6.
WO2009003672A3 (fr) Nouveaux microbiocides
WO2009035959A3 (fr) Methodes de radiofluoration
WO2008083191A3 (fr) Procédés de radiofluoration
TN2009000233A1 (en) Radiolabelling via fluorination of aziridines
WO2009150139A3 (fr) Dérivés d’indolyl-pyridazinyl-diazabicyclononane sous forme marquée et non marquée et leur utilisation dans des procédés diagnostiques